Form 4 · Filed May 28, 2026, 11:43 PM UTC
LGND/LIGAND PHARMACEUTICALS INC
Espinoza Octavio — Chief Financial Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 27, 2026 | M | other | 764 | $64 | $48,606 | 26,707 |
| May 27, 2026 | M | other | 972 | $53 | $51,360 | 27,679 |
| May 27, 2026 | M | other | 972 | — | — | 0 |
| May 27, 2026 | M | other | 764 | — | — | 17,407 |
Source: SEC EDGAR raw filing ↗ · Accession 0002001011-26-000071